TickerKhojComparison · NSE · data 2026-11-02
Parnax Lab Limited vs Vaishali Pharma Ltd.
In plain words
Size: Parnax Lab Limited is about 1.4 times the market value of Vaishali Pharma Ltd..
Valuation (P/E): Vaishali Pharma Ltd. 20 vs Parnax Lab Limited 14.1.
Return on equity: Parnax Lab Limited 13.2% vs Vaishali Pharma Ltd. 6.2%.
Profit growth over 3 years: Parnax Lab Limited 11% a year vs Vaishali Pharma Ltd. -14.2% a year.
Debt to equity: Parnax Lab Limited 0.87 vs Vaishali Pharma Ltd. 0.27.
Differences in the numbers, not a recommendation of either stock.
Side by side
| PARNAXLAB | VAISHALI | |
|---|---|---|
| Price | ₹109.5 | ₹6.55 |
| Market cap | ₹122 cr | ₹87 cr |
| P/E | 14.1 | 20 |
| P/B | — | — |
| ROE | 13.2% | 6.2% |
| ROCE | 18.0% | 3.6% |
| Debt / equity | 0.87 | 0.27 |
| Operating margin | 6.3% | 3.4% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 14.0% | 15.8% |
| Profit growth, 3 years (yearly) | 11.0% | -14.2% |
| 1-year return | 1.4% | -36.1% |
| Revenue, last 12 months | ₹252 cr | ₹108 cr |
| Net profit, last 12 months | ₹9 cr | ₹4 cr |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹2 cr |
| Quarter profit vs a year earlier | — | +21.1% |
| Promoter holding | — | 31.61% |
| Health check | Average (6.3/10) | Average (5.2/10) |
Common questions
Which has a higher P/E, Parnax Lab Limited or Vaishali Pharma Ltd.?
Vaishali Pharma Ltd. trades at the higher P/E (20 against 14.1). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Parnax Lab Limited (13.2% against 6.2%).
Which carries more debt?
Parnax Lab Limited has the higher debt-to-equity ratio (0.87 against 0.27).